BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9203569)

  • 1. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
    Williamson DJ; Shepheard SL; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 Jun; 328(1):61-4. PubMed ID: 9203569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
    Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan has central antinociceptive effects against durally evoked responses.
    Cumberbatch MJ; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 Jun; 328(1):37-40. PubMed ID: 9203565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
    Cumberbatch MJ; Williamson DJ; Mason GS; Hill RG; Hargreaves RJ
    Br J Pharmacol; 1999 Mar; 126(6):1478-86. PubMed ID: 10217543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
    Holland PR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
    Akerman S; Goadsby PJ
    Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of histamine in dural vessel dilation.
    Akerman S; Williamson DJ; Kaube H; Goadsby PJ
    Brain Res; 2002 Nov; 956(1):96-102. PubMed ID: 12426051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
    Shepherd SL; Williamson DJ; Beer MS; Hill RG; Hargreaves RJ
    Neuropharmacology; 1997; 36(4-5):525-33. PubMed ID: 9225277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
    Akerman S; Kaube H; Goadsby PJ
    Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of adrenergic compounds on neurogenic dural vasodilatation.
    Akerman S; Williamson DJ; Hill RG; Goadsby PJ
    Eur J Pharmacol; 2001 Jul; 424(1):53-8. PubMed ID: 11470260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation.
    Andreou AP; Holland PR; Goadsby PJ
    Br J Pharmacol; 2009 Jun; 157(3):464-73. PubMed ID: 19309356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats.
    Williamson DJ; Shepheard SL; Cook DA; Hargreaves RJ; Hill RG; Cumberbatch MJ
    Br J Pharmacol; 2001 Jul; 133(6):807-14. PubMed ID: 11454653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels.
    Akerman S; Williamson DJ; Kaube H; Goadsby PJ
    Eur J Pharmacol; 2002 Oct; 452(2):223-8. PubMed ID: 12354573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat.
    Kowacs F; Williamson DJ; Goadsby PJ
    Eur J Pharmacol; 2004 Jun; 493(1-3):133-7. PubMed ID: 15189774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism.
    Akerman S; Williamson DJ; Goadsby PJ
    Br J Pharmacol; 2003 Oct; 140(3):558-66. PubMed ID: 12970082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine.
    Wang X; Fang Y; Liang J; Yan M; Hu R; Pan X
    J Mol Neurosci; 2014; 54(2):164-70. PubMed ID: 24584680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro.
    Ebersberger A; Averbeck B; Messlinger K; Reeh PW
    Neuroscience; 1999 Mar; 89(3):901-7. PubMed ID: 10199623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
    Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
    Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
    Ma QP; Hill R; Sirinathsinghji D
    Eur J Neurosci; 2001 Jun; 13(11):2099-104. PubMed ID: 11422450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.